ETON 250117 10.00C (ETON250117C10000) Stock Options, News & Quotes

$Eton Pharmaceutical (ETON.US)$ Eton Pharmaceuticals Announced The Full Readout From The Clinical Trial Evaluating PKU GOLIKE As A Protein Substitute For Phenylketonuria In Patients During Prolonged Fasting Periods
Benzinga· 5 mins ago1min
The study demonstrated that PKU GOLIKE, administered as the last daily dose and compared to standard amino acid protein substitutes, improved metabolic control by reducing harmful phenylalanine (Phe) levels and increasing beneficial tyrosine (Tyr) levels,...

Jaguar8

Nov 25 05:54

NEWS

$Eton Pharmaceutical (ETON.US)$
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
Eton Pharmaceuticals has acquired U.S. rights to Amglidia (glyburide oral suspension) from AMMTeK for treating neonatal diabetes mellitus.
The product, already approved by the European Medicines Agency since 2018, has received Orphan Drug Designation from the FDA. Amglidia is a patented liquid formulation targeting approximately 300 U.S. patients with neonatal dia...

Trytosaveabit

Nov 25 05:53

Update

$Eton Pharmaceutical (ETON.US)$ Reuters· 2 mins ago
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Trytosaveabit

Oct 8 17:43

New form 4

$Eton Pharmaceutical (ETON.US)$